2024 Q2 Form 10-Q Financial Statement

#000149322524000092 Filed on May 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $1.570M $1.615M
YoY Change 19.94% 17.03%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $935.0K $943.0K
YoY Change -1.99% 0.32%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense $30.76M
YoY Change 104.67%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $9.171M $8.518M
YoY Change -30.38% -47.54%
Income Tax $3.214M $2.304M
% Of Pretax Income 35.05% 27.05%
Net Earnings $5.957M $6.214M
YoY Change -37.68% -46.92%
Net Earnings / Revenue 379.43% 384.77%
Basic Earnings Per Share $0.14 $0.15
Diluted Earnings Per Share $0.14 $0.15
COMMON SHARES
Basic Shares Outstanding 44.34M shares 44.46M shares
Diluted Shares Outstanding 42.00M shares 42.41M shares

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $153.5M $238.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $23.63M $54.38M
YoY Change -3.85% 120.38%
Goodwill $41.01M $41.01M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $5.746B $5.852B
YoY Change 3.71% 3.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $26.11M $30.20M
YoY Change -10.32% -2.09%
Accrued Expenses $77.69M $75.76M
YoY Change 2.21% -1.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $25.00M
YoY Change -100.0% 0.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $103.8M $131.0M
YoY Change -20.23% -1.15%
LONG-TERM LIABILITIES
Long-Term Debt $1.151B $1.101B
YoY Change 19.95% 11.76%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.151B $1.101B
YoY Change 19.95% 11.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $103.8M $131.0M
Total Long-Term Liabilities $1.151B $1.101B
Total Liabilities $5.053B $5.153B
YoY Change 4.1% 3.79%
SHAREHOLDERS EQUITY
Retained Earnings $434.3M $433.9M
YoY Change 1.49% 2.29%
Common Stock $648.0K $648.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $693.0M $698.4M
YoY Change
Total Liabilities & Shareholders Equity $5.746B $5.852B
YoY Change 3.71% 3.33%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $5.957M $6.214M
YoY Change -37.68% -46.92%
Depreciation, Depletion And Amortization $935.0K $943.0K
YoY Change -1.99% 0.32%
Cash From Operating Activities $6.911M $4.237M
YoY Change 111.47% -76.13%
INVESTING ACTIVITIES
Capital Expenditures $241.0K $451.0K
YoY Change -70.68% -38.97%
Acquisitions
YoY Change
Other Investing Activities $24.05M -$239.0M
YoY Change -57.88% -568.8%
Cash From Investing Activities $23.81M -$239.4M
YoY Change -57.69% -576.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -116.0M $244.5M
YoY Change -10.32% 441.25%
NET CHANGE
Cash From Operating Activities 6.911M $4.237M
Cash From Investing Activities 23.81M -$239.4M
Cash From Financing Activities -116.0M $244.5M
Net Change In Cash -85.29M $9.275M
YoY Change 22.15% -91.8%
FREE CASH FLOW
Cash From Operating Activities $6.911M $4.237M
Capital Expenditures $241.0K $451.0K
Free Cash Flow $6.670M $3.786M
YoY Change 172.69% -77.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedInvestmentIncomeReceivable
CY2024Q1 us-gaap Debt Securities Held To Maturity Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List
DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#AccruedInvestmentIncomeReceivable
CY2024Q1 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
4398000 usd
CY2023Q1 us-gaap Interest Income Securities Mortgage Backed
InterestIncomeSecuritiesMortgageBacked
3792000 usd
CY2024Q1 us-gaap Interest Income Securities Corporate Debt Operating
InterestIncomeSecuritiesCorporateDebtOperating
3841000 usd
CY2023Q1 us-gaap Interest Income Securities Corporate Debt Operating
InterestIncomeSecuritiesCorporateDebtOperating
1385000 usd
CY2024Q1 us-gaap Interest Income Federal Home Loan Bank Advances
InterestIncomeFederalHomeLoanBankAdvances
970000 usd
CY2023Q1 us-gaap Interest Income Federal Home Loan Bank Advances
InterestIncomeFederalHomeLoanBankAdvances
465000 usd
CY2024Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
3392000 usd
CY2023Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
578000 usd
CY2024Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
58648000 usd
CY2023Q1 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
49927000 usd
CY2024Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
19273000 usd
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
7821000 usd
CY2024Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
10663000 usd
CY2023Q1 us-gaap Interest Expense Borrowings
InterestExpenseBorrowings
6391000 usd
CY2024Q1 nfbk Interest Expense Subordinated Debt
InterestExpenseSubordinatedDebt
828000 usd
CY2023Q1 nfbk Interest Expense Subordinated Debt
InterestExpenseSubordinatedDebt
819000 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
30764000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
15031000 usd
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
27884000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
34896000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
415000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
864000 usd
CY2024Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
27469000 usd
CY2023Q1 us-gaap Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
34032000 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1615000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1380000 usd
CY2024Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
964000 usd
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
870000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
0 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
1000 usd
CY2024Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
699000 usd
CY2023Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
512000 usd
CY2024Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
103000 usd
CY2023Q1 us-gaap Noninterest Income Other Operating Income
NoninterestIncomeOtherOperatingIncome
569000 usd
CY2024Q1 us-gaap Noninterest Income
NoninterestIncome
3381000 usd
CY2023Q1 us-gaap Noninterest Income
NoninterestIncome
3332000 usd
CY2024Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
12765000 usd
CY2023Q1 us-gaap Labor And Related Expense
LaborAndRelatedExpense
11037000 usd
CY2024Q1 us-gaap Occupancy Net
OccupancyNet
3553000 usd
CY2023Q1 us-gaap Occupancy Net
OccupancyNet
3372000 usd
CY2024Q1 us-gaap Equipment Expense
EquipmentExpense
484000 usd
CY2023Q1 us-gaap Equipment Expense
EquipmentExpense
454000 usd
CY2024Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2147000 usd
CY2023Q1 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
2243000 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
809000 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
971000 usd
CY2024Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
518000 usd
CY2023Q1 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
847000 usd
CY2024Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
588000 usd
CY2023Q1 us-gaap Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
604000 usd
CY2024Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
83000 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
111000 usd
CY2024Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1385000 usd
CY2023Q1 us-gaap Other Noninterest Expense
OtherNoninterestExpense
1489000 usd
CY2024Q1 us-gaap Noninterest Expense
NoninterestExpense
22332000 usd
CY2023Q1 us-gaap Noninterest Expense
NoninterestExpense
21128000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8518000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16236000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2304000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4529000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
6214000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11707000 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
6214000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11707000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
976000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
8397000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
1000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
976000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
8396000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-58000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
1034000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
8396000 usd
CY2024Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
275000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
2350000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
-16000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
743000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6046000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6957000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
17753000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
701390000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11707000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6046000 usd
CY2023Q1 us-gaap Amortization Of Esop Award
AmortizationOfESOPAward
393000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
718000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q1 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
100000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.13
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.13
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
5912000 usd
CY2023Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
14.68
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
16276000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
698166000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
699445000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
743000 usd
CY2024Q1 us-gaap Amortization Of Esop Award
AmortizationOfESOPAward
283000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
620000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2024Q1 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
0 usd
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.13
CY2024Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.13
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
5563000 usd
CY2024Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
223000 usd
CY2024Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
12.17
CY2024Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3090000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
698429000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
6214000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11707000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
415000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
864000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
903000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1111000 usd
CY2024Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
921000 usd
CY2023Q1 us-gaap Depreciation Nonproduction
DepreciationNonproduction
909000 usd
CY2024Q1 nfbk Amortization Of Premiums And Deferred Loan Costs
AmortizationOfPremiumsAndDeferredLoanCosts
-592000 usd
CY2023Q1 nfbk Amortization Of Premiums And Deferred Loan Costs
AmortizationOfPremiumsAndDeferredLoanCosts
1940000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
56000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
56000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
31000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1188000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1168000 usd
CY2024Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
964000 usd
CY2023Q1 us-gaap Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
870000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
0 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
1000 usd
CY2024Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
699000 usd
CY2023Q1 us-gaap Debt And Equity Securities Gain Loss
DebtAndEquitySecuritiesGainLoss
512000 usd
CY2024Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
-522000 usd
CY2023Q1 us-gaap Increase Decrease In Trading Securities
IncreaseDecreaseInTradingSecurities
-134000 usd
CY2024Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
867000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-230000 usd
CY2024Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3977000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1909000 usd
CY2024Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
1095000 usd
CY2023Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-925000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4237000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17751000 usd
CY2024Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-40038000 usd
CY2023Q1 us-gaap Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
-3058000 usd
CY2024Q1 us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
0 usd
CY2023Q1 us-gaap Payments To Acquire Finance Receivables
PaymentsToAcquireFinanceReceivables
3781000 usd
CY2024Q1 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
437000 usd
CY2023Q1 us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
21198000 usd
CY2024Q1 nfbk Redemptions Of Federal Home Loan Bank Stock
RedemptionsOfFederalHomeLoanBankStock
256000 usd
CY2023Q1 nfbk Redemptions Of Federal Home Loan Bank Stock
RedemptionsOfFederalHomeLoanBankStock
10463000 usd
CY2024Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
459710000 usd
CY2023Q1 us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
0 usd
CY2024Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
409000 usd
CY2023Q1 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
0 usd
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
181234000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
62063000 usd
CY2024Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
56000 usd
CY2023Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
370000 usd
CY2024Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
451000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
739000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-239423000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
50236000 usd
CY2024Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
42888000 usd
CY2023Q1 us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-302722000 usd
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5563000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5912000 usd
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000 usd
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3313000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16276000 usd
CY2024Q1 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
5100000 usd
CY2023Q1 us-gaap Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance
IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance
4852000 usd
CY2024Q1 nfbk Proceeds From Fhlb Advances And Other Borrowings And Securities Sold Under Agreements To Repurchase
ProceedsFromFHLBAdvancesAndOtherBorrowingsAndSecuritiesSoldUnderAgreementsToRepurchase
300000000 usd
CY2023Q1 nfbk Proceeds From Fhlb Advances And Other Borrowings And Securities Sold Under Agreements To Repurchase
ProceedsFromFHLBAdvancesAndOtherBorrowingsAndSecuritiesSoldUnderAgreementsToRepurchase
617788000 usd
CY2024Q1 nfbk Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
94651000 usd
CY2023Q1 nfbk Payments For Securities Sold Under Agreements To Repurchase
PaymentsForSecuritiesSoldUnderAgreementsToRepurchase
252664000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
244461000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45166000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
9275000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
113153000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
229506000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45799000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
238781000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
158952000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
31062000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
13527000 usd
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1443000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1391000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoffAfterRecovery
911000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoffAfterRecovery
2045000 usd
CY2024Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
0 usd
CY2023Q1 us-gaap Transfer To Other Real Estate
TransferToOtherRealEstate
70000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1060000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
1119786000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
779000 usd
CY2024Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
44824000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
1075741000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
840485000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
60000 usd
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
45081000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
795464000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Restricted
DebtSecuritiesAvailableForSaleRestricted
471700000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Restricted
DebtSecuritiesAvailableForSaleRestricted
272900000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
0 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
1000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Realized Loss
DebtSecuritiesAvailableForSaleRealizedLoss
0 usd
CY2024Q1 us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
699000 usd
CY2023Q1 us-gaap Debt Securities Trading Realized Gain Loss
DebtSecuritiesTradingRealizedGainLoss
512000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
83000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
140328000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
44741000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
627367000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
44824000 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
767695000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
9000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
10746000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
45072000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
721424000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss
DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss
45081000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
732170000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
0 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Amortized Cost Allowance For Credit Loss Excluding Accrued Interest
DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest
0 usd
CY2024Q1 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
3100000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
2400000 usd
CY2024Q1 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss
9810000 usd
CY2024Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
52000 usd
CY2024Q1 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
498000 usd
CY2024Q1 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
9364000 usd
CY2023Q4 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityExcludingAccruedInterestAfterAllowanceForCreditLoss
9866000 usd
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
107000 usd
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
387000 usd
CY2023Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
9586000 usd
CY2024Q1 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Sale
DebtSecuritiesHeldToMaturityExcludingAccruedInterestSale
0 usd
CY2023Q1 us-gaap Debt Securities Held To Maturity Excluding Accrued Interest Sale
DebtSecuritiesHeldToMaturityExcludingAccruedInterestSale
0 usd
CY2024Q1 us-gaap Held To Maturity Securities Restricted
HeldToMaturitySecuritiesRestricted
9700000 usd
CY2023Q4 us-gaap Held To Maturity Securities Restricted
HeldToMaturitySecuritiesRestricted
9700000 usd
CY2024Q1 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
0 usd
CY2024Q1 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
0 usd
CY2024Q1 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
498000 usd
CY2024Q1 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
6505000 usd
CY2024Q1 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
498000 usd
CY2024Q1 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
6505000 usd
CY2023Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
0 usd
CY2023Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
0 usd
CY2023Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
387000 usd
CY2023Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
6661000 usd
CY2023Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
387000 usd
CY2023Q4 us-gaap Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
6661000 usd
CY2024Q1 nfbk Debt Securities Held To Maturity Unrealized Loss Position Greater Than Twelve Months Number Of Positions
DebtSecuritiesHeldToMaturityUnrealizedLossPositionGreaterThanTwelveMonthsNumberOfPositions
9 security
CY2024Q1 us-gaap Debt Securities Held To Maturity Accrued Interest After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss
35000 usd
CY2023Q4 us-gaap Debt Securities Held To Maturity Accrued Interest After Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAccruedInterestAfterAllowanceForCreditLoss
36000 usd
CY2024Q1 us-gaap Equity Securities Fv Ni And Without Readily Determinable Fair Value
EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
11000000 usd
CY2023Q4 us-gaap Equity Securities Fv Ni And Without Readily Determinable Fair Value
EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue
10600000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
4162472000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
4203654000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
37039000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
37535000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
4125433000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
4166119000 usd
CY2023Q4 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
0 usd
CY2024Q1 us-gaap Loans Receivable Held For Sale Amount
LoansReceivableHeldForSaleAmount
0 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual
FinancingReceivableExcludingAccruedInterestNonaccrual
16800000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual
FinancingReceivableExcludingAccruedInterestNonaccrual
10100000 usd
CY2024Q1 nfbk Delinquent Status Classification Criteria Days Minimum
DelinquentStatusClassificationCriteriaDaysMinimum
P90D
CY2024Q1 nfbk Delinquent Status Classification Criteria Days Minimum
DelinquentStatusClassificationCriteriaDaysMinimum
P90D
CY2024Q1 nfbk Principal Balance Threshold For Non Accrual Status
PrincipalBalanceThresholdForNonAccrualStatus
500000 usd
CY2024Q1 nfbk Loans Deemed To Be Impaired Non Accrual Amount
LoansDeemedToBeImpairedNonAccrualAmount
10400000 usd
CY2023Q4 nfbk Loans Deemed To Be Impaired Non Accrual Amount
LoansDeemedToBeImpairedNonAccrualAmount
6000000 usd
CY2024Q1 nfbk Principal Balance Threshold For Non Accrual Status
PrincipalBalanceThresholdForNonAccrualStatus
500000 usd
CY2024Q1 nfbk Loans On Non Accrual Status With Principal Balances Below Threshold Definition Of Impaired Loan
LoansOnNonAccrualStatusWithPrincipalBalancesBelowThresholdDefinitionOfImpairedLoan
6400000 usd
CY2023Q4 nfbk Loans On Non Accrual Status With Principal Balances Below Threshold Definition Of Impaired Loan
LoansOnNonAccrualStatusWithPrincipalBalancesBelowThresholdDefinitionOfImpairedLoan
4100000 usd
CY2023 nfbk Delinquent Status Classification Criteria Days Minimum
DelinquentStatusClassificationCriteriaDaysMinimum
P90D
CY2024Q1 nfbk Delinquent Status Classification Criteria Days Minimum
DelinquentStatusClassificationCriteriaDaysMinimum
P90D
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest90 Days Or More Past Due Still Accruing
FinancingReceivableExcludingAccruedInterest90DaysOrMorePastDueStillAccruing
453000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest90 Days Or More Past Due Still Accruing
FinancingReceivableExcludingAccruedInterest90DaysOrMorePastDueStillAccruing
1300000 usd
CY2023 nfbk Delinquent Status Classification Criteria Days Minimum
DelinquentStatusClassificationCriteriaDaysMinimum
P90D
CY2024Q1 nfbk Delinquent Status Classification Criteria Days Minimum
DelinquentStatusClassificationCriteriaDaysMinimum
P90D
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual
FinancingReceivableExcludingAccruedInterestNonaccrual
16788000 usd
CY2024Q1 nfbk Financing Receivable Excluding Accrued Interest Nonaccrual Unpaid Principal Balance
FinancingReceivableExcludingAccruedInterestNonaccrualUnpaidPrincipalBalance
22569000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual No Allowance
FinancingReceivableExcludingAccruedInterestNonaccrualNoAllowance
10410000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual
FinancingReceivableExcludingAccruedInterestNonaccrual
10115000 usd
CY2023Q4 nfbk Financing Receivable Excluding Accrued Interest Nonaccrual Unpaid Principal Balance
FinancingReceivableExcludingAccruedInterestNonaccrualUnpaidPrincipalBalance
15197000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Nonaccrual No Allowance
FinancingReceivableExcludingAccruedInterestNonaccrualNoAllowance
6042000 usd
CY2024Q1 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
184000 usd
CY2023Q1 us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
98000 usd
CY2024Q1 nfbk Financing Receivable Impaired Secured By Collateral
FinancingReceivableImpairedSecuredByCollateral
12200000 usd
CY2023Q4 nfbk Financing Receivable Impaired Secured By Collateral
FinancingReceivableImpairedSecuredByCollateral
7900000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Modified Period
FinancingReceivableExcludingAccruedInterestModifiedPeriod
15104000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Modified Accumulated
FinancingReceivableExcludingAccruedInterestModifiedAccumulated
16759000 usd
CY2024Q1 nfbk Financing Receivable Threshold Individually Evaluated For Impairment
FinancingReceivableThresholdIndividuallyEvaluatedForImpairment
500000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
44300 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
45200 usd
CY2023Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
236000 usd
CY2022Q4 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
791000 usd
CY2024Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
83000 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
111000 usd
CY2024Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
319000 usd
CY2023Q1 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
902000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
37535000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
950000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
39000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
415000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
37039000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
42617000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Writeoff
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossWriteoff
2064000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Allowance For Credit Loss Recovery
FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossRecovery
19000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
864000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
41436000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
37000000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
37500000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
44000 usd
CY2024Q1 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
33930000 usd
CY2024Q1 nfbk Financing Receivable Allowance For Credit Losses Pcd Loans Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesPCDLoansEvaluatedForImpairment
3065000 usd
CY2024Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
4162472000 usd
CY2024Q1 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
13569000 usd
CY2024Q1 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
4138707000 usd
CY2024Q1 nfbk Financing Receivables Pcd Loans Evaluated For Impairment
FinancingReceivablesPCDLoansEvaluatedForImpairment
9953000 usd
CY2024Q1 nfbk Financing Receivable Not Evaluated For Impairment
FinancingReceivableNotEvaluatedForImpairment
243000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
45000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
34405000 usd
CY2023Q4 nfbk Financing Receivable Allowance For Credit Losses Pcd Loans Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesPCDLoansEvaluatedForImpairment
3085000 usd
CY2023Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
4203654000 usd
CY2023Q4 us-gaap Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
9324000 usd
CY2023Q4 us-gaap Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
4184147000 usd
CY2023Q4 nfbk Financing Receivables Pcd Loans Evaluated For Impairment
FinancingReceivablesPCDLoansEvaluatedForImpairment
9899000 usd
CY2023Q4 nfbk Financing Receivable Not Evaluated For Impairment
FinancingReceivableNotEvaluatedForImpairment
284000 usd
CY2024Q1 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
693671000 usd
CY2023Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
694903000 usd
CY2024Q1 us-gaap Deposits Negotiable Order Of Withdrawal Now
DepositsNegotiableOrderOfWithdrawalNOW
1277161000 usd
CY2023Q4 us-gaap Deposits Negotiable Order Of Withdrawal Now
DepositsNegotiableOrderOfWithdrawalNOW
1231943000 usd
CY2024Q1 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
1197230000 usd
CY2023Q4 us-gaap Deposits Savings Deposits
DepositsSavingsDeposits
1277866000 usd
CY2024Q1 us-gaap Time Deposits
TimeDeposits
753261000 usd
CY2023Q4 us-gaap Time Deposits
TimeDeposits
673723000 usd
CY2024Q1 us-gaap Deposits
Deposits
3921323000 usd
CY2023Q4 us-gaap Deposits
Deposits
3878435000 usd
CY2024Q1 us-gaap Interest Expense Domestic Deposit Liabilities Demand
InterestExpenseDomesticDepositLiabilitiesDemand
12331000 usd
CY2023Q1 us-gaap Interest Expense Domestic Deposit Liabilities Demand
InterestExpenseDomesticDepositLiabilitiesDemand
3843000 usd
CY2024Q1 us-gaap Interest Expense Domestic Deposit Liabilities Certificates Of Deposit
InterestExpenseDomesticDepositLiabilitiesCertificatesOfDeposit
6942000 usd
CY2023Q1 us-gaap Interest Expense Domestic Deposit Liabilities Certificates Of Deposit
InterestExpenseDomesticDepositLiabilitiesCertificatesOfDeposit
3978000 usd
CY2024Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
19273000 usd
CY2023Q1 us-gaap Interest Expense Deposits
InterestExpenseDeposits
7821000 usd
CY2024Q1 us-gaap Subordinated Debt
SubordinatedDebt
61300000 usd
CY2023Q4 us-gaap Subordinated Debt
SubordinatedDebt
61200000 usd
CY2024Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
725000 usd
CY2023Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
781000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1544306 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1544306 shares
CY2023Q4 nfbk Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
4.03
CY2023Q4 nfbk Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
4.03
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
14.05
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.05
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y3D
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y3D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1544306 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1544306 shares
CY2024Q1 nfbk Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue
4.03
CY2024Q1 nfbk Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
4.03
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
14.05
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.05
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y9M3D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y9M3D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
364083 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
14.34
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
237721 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
13.28
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
146968 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
14.34
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
10659 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
12.43
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
444177 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
13.82
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
620000 usd
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
718000 usd
CY2024Q1 nfbk Investment Owned At Net Asset Value
InvestmentOwnedAtNetAssetValue
10000000 usd
CY2023Q4 nfbk Investment Owned At Net Asset Value
InvestmentOwnedAtNetAssetValue
10300000 usd
CY2024Q1 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
4180000 usd
CY2023Q4 us-gaap Loans Receivable Fair Value Disclosure
LoansReceivableFairValueDisclosure
4277000 usd
CY2024Q1 nfbk Principal Amount Outstanding Of Impaired Loans Heldfor Investment Heldfor Sale
PrincipalAmountOutstandingOfImpairedLoansHeldforInvestmentHeldforSale
5900000 usd
CY2023Q4 nfbk Principal Amount Outstanding Of Impaired Loans Heldfor Investment Heldfor Sale
PrincipalAmountOutstandingOfImpairedLoansHeldforInvestmentHeldforSale
6000000 usd
CY2024Q1 nfbk Estimated Fair Value Of Impaired Loans Held For Investment
EstimatedFairValueOfImpairedLoansHeldForInvestment
4200000 usd
CY2023Q4 nfbk Estimated Fair Value Of Impaired Loans Held For Investment
EstimatedFairValueOfImpairedLoansHeldForInvestment
4300000 usd
CY2024Q1 nfbk Impaired Financing Receivable Reserve Increase Decrease
ImpairedFinancingReceivableReserveIncreaseDecrease
900 usd
CY2023Q1 nfbk Impaired Financing Receivable Reserve Increase Decrease
ImpairedFinancingReceivableReserveIncreaseDecrease
7000 usd
CY2024Q1 nfbk Impaired Financing Receivables Charge Off
ImpairedFinancingReceivablesChargeOff
911000 usd
CY2023Q1 nfbk Impaired Financing Receivables Charge Off
ImpairedFinancingReceivablesChargeOff
2000000 usd
CY2024Q1 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
0 usd
CY2023Q4 us-gaap Real Estate Acquired Through Foreclosure
RealEstateAcquiredThroughForeclosure
0 usd
CY2024Q1 nfbk Investment Owned At Net Asset Value
InvestmentOwnedAtNetAssetValue
10000000 usd
CY2023Q4 nfbk Investment Owned At Net Asset Value
InvestmentOwnedAtNetAssetValue
10300000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
6214000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
11707000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
42367243 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44784228 shares
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
41710 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
144677 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42408953 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44928905 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1860882 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
920352 shares
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30100000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
34900000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30200000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
35200000 usd
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1487000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1507000 usd
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1092000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
906000 usd
CY2024Q1 us-gaap Lease Cost
LeaseCost
2579000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
2413000 usd
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1623000 usd
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1606000 usd
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1060000 usd
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y10M24D
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y1M13D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0363
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0355
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4707000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
6028000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5265000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4304000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4038000 usd
CY2024Q1 nfbk Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
19383000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
43725000 usd
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
8783000 usd
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
34942000 usd
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493225-24-000092-index-headers.html Edgar Link pending
0001493225-24-000092-index.html Edgar Link pending
0001493225-24-000092.txt Edgar Link pending
0001493225-24-000092-xbrl.zip Edgar Link pending
ex311-2024x3x31.htm Edgar Link pending
ex312-2024x3x31.htm Edgar Link pending
ex32-2024x3x31.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nfbk-20240331.htm Edgar Link pending
nfbk-20240331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
nfbk-20240331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
nfbk-20240331_def.xml Edgar Link unprocessable
nfbk-20240331_lab.xml Edgar Link unprocessable
nfbk-20240331_pre.xml Edgar Link unprocessable
nfbk-20240331_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending